Kevin Joseph Fitzgerald - 01 Jul 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
Issuer symbol
ALNY
Transactions as of
01 Jul 2025
Net transactions value
$0
Form type
4
Filing time
02 Jul 2025, 16:26:48 UTC
Previous filing
05 Mar 2025
Next filing
19 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fitzgerald Kevin Joseph CSO & EVP, Head of Research 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald 02 Jul 2025 0001886431

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Award $0 +7,763 +57% $0.000000 21,264 01 Jul 2025 Direct F1
holding ALNY Common Stock 537 01 Jul 2025 by Managed Account F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
F2 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.